Custom circular RNA synthesis requires coordinated control of sequence design, linear precursor production, circularization chemistry, impurity removal, and confirmation of the back-splice or ligation junction. Unlike a linear RNA, the final molecule has no free 5′ or 3′ end, so circularization efficiency and purification depend strongly on precursor structure and the selected joining method. Our custom circular RNA synthesis service supports research teams developing coding or noncoding circRNA constructs, endogenous circRNA mimics, reporter systems, binding tools, and other sequence-defined circular RNA models.
We support project planning from DNA template or customer-supplied sequence through in vitro transcription, circularization, purification, and analytical characterization. Depending on sequence length and the need for scarless joining, projects may use ligase-mediated circularization, splint-assisted strategies, or ribozyme/permuted intron-exon approaches after feasibility review. Design choices are made around the intended research use, junction sequence, acceptable auxiliary sequence, expression architecture, and impurity profile.
Circularization Efficiency: RNA ends must adopt a geometry compatible with intramolecular joining, while competing secondary structure can hide the ligation site or favor side products. We evaluate precursor architecture and joining strategy before production.
Junction Design: For scarless or sequence-faithful constructs, the ligation junction must be chosen carefully. Ribozyme-based systems may introduce auxiliary sequence constraints, whereas ligase approaches can impose terminal sequence or structural requirements.
Linear RNA Byproducts: Unreacted precursor, nicked species, concatemers, excised introns, and other reaction products can resemble circRNA in size. Purification therefore requires a method selected for the actual reaction pathway rather than a single generic cleanup step.
IVT Impurities: Long circRNA workflows that begin with in vitro transcription can generate truncated transcripts or double-stranded RNA byproducts. These impurities may interfere with downstream research and can be evaluated using project-appropriate analytical methods, including complementary dsRNA detection where relevant.
Functional Architecture: Coding circRNA requires internal translation-initiation architecture, while noncoding constructs may depend on exact sequence, structure, or interaction motifs. We separate circularization requirements from the biological design goal so that one does not unintentionally compromise the other.
Our circRNA workflow is configured around construct size, sequence fidelity, circularization route, and downstream research objective. We support both customer-designed sequences and projects that need technical review of the circularization architecture before production.
Related RNA production and analytical needs can be coordinated with custom ssRNA synthesis, RNA purification, and RNA characterization workflows.
No single circularization method is optimal for every RNA. Sequence length, allowed scar sequence, terminal requirements, and downstream application should drive method selection.
| Method | Best-Fit Construct Profile | Key Design Requirement | Main Advantages | Key Limitations |
| T4 RNA ligase-based circularization | Small to medium RNA; projects prioritizing direct enzymatic joining | Accessible ends and compatible terminal chemistry | Conceptually direct; can support scarless junctions | Strongly sequence/structure dependent; intermolecular products can compete |
| Splint-assisted ligation | Constructs needing defined end alignment | Complementary DNA/RNA splint around the junction | Improves end proximity and junction control | Requires careful splint and junction design; purification must remove auxiliary oligo |
| PIE / group I intron strategy | Longer IVT-derived circRNA and selected coding constructs | Compatible intron-exon architecture and splice junction | Circularization coupled to self-splicing; useful for larger RNAs | Can introduce sequence constraints or scar elements; generates splicing byproducts |
| Scarless PIE-type strategy | Longer circRNA where native sequence preservation is important | Engineered splice architecture that accommodates the target junction | Reduces or avoids unwanted retained exon sequence | Design is more sequence dependent and requires method-specific optimization |
| Hybrid/alternative enzymatic strategy | Specialized constructs not well served by a single standard route | Custom terminal or ribozyme architecture | Can address unusual sequence or topology constraints | Feasibility must be established project by project |
Circular topology should be supported by multiple lines of evidence because linear and circular RNAs can share similar size and sequence composition.
| Quality Question | Useful Analytical Approach | What It Shows | Important Limitation | Project Stage |
| Is the RNA the expected size? | Denaturing gel, capillary electrophoresis, or suitable size analysis | Integrity and major size-related impurities | Migration can differ between linear and circular forms | Post-purification |
| Is residual linear precursor present? | Orthogonal separation plus enzymatic challenge where appropriate | Relative presence of linear species | Enzyme resistance alone is not definitive for topology | Purification development |
| Is the circular junction correct? | Junction-specific RT-PCR followed by sequence confirmation where appropriate | Sequence continuity across the joining site | Reverse transcription can introduce artifacts if poorly controlled | Identity confirmation |
| Are IVT byproducts present? | Chromatographic, electrophoretic, or dsRNA-focused assays | Presence of process-related impurities | Method must match RNA size and impurity type | IVT and purification |
| Is the RNA circularization method behaving consistently? | Product distribution analysis across reaction conditions | Relative precursor, circle, concatemer, and side-product patterns | Not all species resolve in one analytical method | Process optimization |
| Is the construct suitable for downstream work? | Concentration, integrity, formulation, and project-specific functional assay | Readiness for the intended research workflow | Functional assay results depend on the downstream biological system | Final release / handoff |
Circular RNA production is managed as a linked design-production-purification problem, with the junction and impurity profile considered from the beginning.
Confirm the intended circRNA sequence, coding or noncoding objective, acceptable junction constraints, quantity, required auxiliary elements, and downstream research format.
Select ligase, splint-assisted, PIE, or another feasible route based on length, structure, scar tolerance, terminal requirements, and expected byproducts.
Prepare or receive the DNA template and produce the linear RNA precursor under conditions selected for the chosen circularization route.
Execute the planned intramolecular joining or self-splicing process and optimize critical conditions when the sequence requires it.
Remove major linear and process-related impurities, then evaluate integrity, product distribution, and the circular junction using the agreed orthogonal methods.
Provide the purified circRNA in the agreed buffer and concentration with construct information, analytical documentation, and handling guidance for the research program.
Reliable circRNA production depends on linking sequence architecture to circularization chemistry and analytical strategy.
Synthetic circRNA provides a controlled way to study how covalently closed RNA topology changes stability, expression, molecular interactions, and assay behavior.
To evaluate a circRNA project, provide the full sequence or construct map, expected size, coding or noncoding objective, desired junction or scar constraints, quantity, purity expectations, and intended downstream assay. We can review the most appropriate circularization route, identify likely sequence constraints, and define a purification and characterization plan before production begins. Contact us to discuss a custom circular RNA research construct.
Common approaches include enzymatic ligation, splint-assisted ligation, and ribozyme-based methods such as permuted intron-exon systems. Method selection depends on sequence length, junction requirements, and tolerance for auxiliary sequence.
Scarless designs preserve the intended RNA sequence across the joining site, while some ribozyme-based approaches retain short sequence elements required for circularization. The acceptable architecture depends on the research objective.
Circularity is best supported by orthogonal evidence such as product-size analysis, enzymatic challenge where appropriate, and sequence confirmation across the circular junction. RNase R resistance alone is not a complete identity test.
Yes. Coding circRNA constructs can be designed with an internal translation-initiation architecture and an open reading frame, provided that circularization and junction requirements are considered during construct design.
Potential impurities include unreacted linear precursor, truncated transcripts, excised intron fragments, concatemers, nicked species, and IVT-related byproducts such as double-stranded RNA. The impurity profile depends on the production method.
Loading ......
